FGEN vs NVST · rev $29.6M vs P/E 56, rev $1.44B
FibroGen Inc (FGEN) versus Envista Holdings Corp (NVST) — a side-by-side from cached financials, not a winner call.
FibroGen Inc (FGEN) is a biotechnology company listed on NASDAQ.
Envista Holdings Corp (NVST) is a medical instruments & supplies company listed on US.
Latest reported FGEN revenue for 2024-12-31 was $29.6M. Net income was -$47.6M. Revenue was down 36.7% from 2023-12-31 to 2024-12-31. FGEN currently screens at market cap $39.3M.
Latest reported NVST revenue for 2026-07-03 was $1.44B. Net income was $92.4M. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
FGEN currently screens at market cap $39.3M. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
Not investment advice. Open the FGEN and NVST stock pages for the full models.
Not investment advice.